Classified by application
All Products
Signaling Pathways
- Angiogenesis/Protein Tyrosine Kinase
- Apoptosis Pathway
- Cell Cycle/DNA Damage
- Epigenetics
-
GPCR/G Protein
- Urotensin Receptor
- Melatonin Receptor
- Neurotensin Receptor
- Glucose Transporter
- Cholecystokinin Receptor
- TGR5
- Motilin Receptor
- Adenylate Cyclase
- Oxytocin Receptor
- Somatostatin Receptor
- Bradykinin Receptor
- Guanylate Cyclase
- Melanocortin Receptor
- Imidazoline Receptor
- Neuropeptide Receptor
- PAR
- CRFR
- Sigma Receptor
- S1P Receptor
- GHSR
- PKA
- OX Receptor
- Adenosine Receptor
- Glucagon Receptor
- Prostaglandin Receptor
- NK Receptor
- GnRH Receptor
- Leukotriene Receptor
- Glucocorticoid Receptor
- mAChR
- P2 Receptor
- GPR
- CGRP Receptor
- CXCR
- Histamine Receptor
- CaSR
- Ras/Rho
- Vasopressin Receptor
- Smoothened/Smo
- Opioid Receptor
- mGluR
- Dopamine Receptor
- Cannabinoid Receptor
- Angiotensin Receptor
- Adrenergic Receptor
- SGLT
- Endothelin Receptor
- CCR
- 5 HT Receptor/Serotonin Receptor
- Hormone Pathay
- Ion Channel/Membrane Transporter
- Jak/Stat Pathway
- MAPK Pathway
- Microbiology/Virology
-
Neuro Signaling Pathway
- Monoamine Oxidase
- Imidazoline Receptor
- COMT
- Amyloid β
- NK Receptor
- Beta secretase
- AChE
- SSRI
- CaMK
- P glycoprotein
- Opioid Receptor
- Dopamine Receptor
- Adrenergic Receptor
- Histamine Receptor
- mGluR
- Gamma secretase
- Dopamine Transporter
- 5 HT Receptor/Serotonin Receptor
- P2 Receptor
- FAAH
- CGRP Receptor
- nAChR
- COX
- GABA Receptor
- mAChR
- NFκB
- PI3K/Akt/mTOR
-
Protease/Metabolic Enzyme
- Xanthine Oxidase
- ACC
- Mitochondrial Metabolism
- Pyruvate Kinase
- ALDH
- SCD
- Serine Protease
- CETP
- Neprilysin
- FTase
- MLR
- MAGL
- E1 E2 E3 Enzyme
- Carbonic Anhydrase
- Elastase
- PAI1
- NOX
- ROR
- Glucokinase
- Aldose Reductase
- Tyrosinase
- FAS
- DGAT
- Lipoxygenase
- Nampt
- IDO
- IDH
- MMP
- Cathepsin
- Phosphatase
- Thrombin
- RAR/RXR
- FXR
- HMGCR
- FAAH
- RAAS/ACE
- Gamma secretase
- Caspase
- HIV Protease
- Aminopeptidase
- HCV Protease
- HSP
- Tryptophan Hydroxylase/TPH
- Factor Xa
- DPP
- Procollagen C Proteinase
- Integrase
- Phospholipase
- Phosphodiesterase/PDE
- LXR
- Proteasome
- Cytochrome P450
- Carboxypeptidase
- 11β HSD
- COMT
- TGF beta/Smad
- Wnt/Stem Cell
- Others Pathway
Research Areas
- Metabolic Disease
- Neurological Disease
- Diabetes
- Endocrinology
- Cardiovascular Disease
- Immunology
- Allergy
- Inflammation
- Infection
- Cancer
Nature products
Antibodies
Peptides
Catalysts
Impurities
Intermediate
- Amino acid
- Pyrazole Series
- Quinazoline
- Nucleoside Series
- Azaindazole
- Ammonia Series
- Pyridazine Series
- Quinoline Series
- Pyrimidine Series
- Boric acid
- Pyrrole Series
- Thiophene Series
- Saccharide
- Azaindole
- Indole Series
- Piperidine Series
- Indazole Series
- Heterocyclic Series
- Pyridine Series
- Benzene Series
Raw Materials
FLT3
Chemical Structure | Cat. No. | Product Name | CAS No. |
---|
![]() |
BCP46930 | KG5 New | 877874-85-6 |
KG 5 is an orally available PDGFRß and B-Raf allosteric inhibitor.
|
![]() |
BCP46381 | MAX-40279 hemifumarate New | 2388506-43-0 |
MAX-40279 hemifumarate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase.
|
![]() |
BCP46003 | MAX-40279 hemiadipate New | 2388506-44-1 |
MAX-40279 hemiadipate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase.
|
![]() |
BCP46002 | MAX-40279 New | 2070931-57-4 |
MAX-40279 is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) and FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2), with potential antineoplastic activity.
|
![]() |
BCP45355 | FLT3-IN-3 New | 2229050-90-0 |
FLT3-IN-3 is a potent and selective FLT3 inhibitor.
|
![]() |
BCP40967 | HM43239 New | 2569527-64-4 |
HM43239 is an orally active small molecule inhibitor of FLT3 that selectively inhibits not only FLT3 wild type, ITD mutants or TKD mutations, but also FLT3 ITD/TKD double mutations.
|
![]() |
BCP42651 | SB1317 New | 1204918-72-8 |
SB1317 is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9). It is one of a number of CDK inhibitors under investigation; others targeting CDK9 for the treatment of acute myeloid leukemia include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80 percent of glioblastomas characterized by this property.
|
![]() |
BCP33271 | CA-4948 New | 1801344-14-8 |
CA-4948 is a potent IRAK4/FLT3 inhibtor with anti-tumor activity.
|
![]() |
BCP36467 | UNC2025 hydrochloride New | 2070015-17-5 |
UNC-2025 hydrochloride is the hydrochloride salt of UNC-2025, which is the Mer/FLT3 dual inhibitor.
|
![]() |
BCP35054 | TG-89 New | 936091-56-4 |
TG-89 is an inhibitor of JAK2, FLT3, RET and JAK3.
|
